AdaptHealth (AHCO) Earnings Date, Estimates & Call Transcripts $10.05 -0.12 (-1.18%) (As of 12/24/2024 02:12 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AdaptHealth Latest Earnings SummaryActual EPS (Nov. 5) $0.15 Missed By -$0.02 Consensus EPS (Nov. 5) $0.17 AdaptHealth released Q3 2024 earnings on November 5, 2024, reporting an EPS of $0.15, which missed analysts' consensus estimates of $0.17 by $0.02. Quarterly revenue rose .2% year-over-year to $805.90 million, below the consensus estimate of $809.32 million. With a trailing EPS of -$1.65, AdaptHealth's earnings are expected to grow 7.95% next year, from $0.88 to $0.95 per share. Conference CallConference Call TranscriptPowered by Get AdaptHealth Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AdaptHealth and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAHCO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AHCO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. AdaptHealth Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242$0.05$0.07$0.06Q2 20242$0.10$0.21$0.16Q3 20242$0.15$0.18$0.17Q4 20242$0.16$0.44$0.30FY 20248$0.46$0.90$0.68Q1 20251$0.15$0.15$0.15Q2 20251$0.21$0.21$0.21Q3 20251$0.22$0.22$0.22Q4 20251$0.43$0.43$0.43FY 20254$1.01$1.01$1.01 AdaptHealth Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/5/2024Q3 2024$0.17$0.15 -$0.02$0.25$809.32M$805.90M8/6/2024Q2 2024$0.19$0.13 -$0.06$0.23$802.62M$805.98M5/7/2024Q1 2024$0.06$0.02 -$0.04$0.06$771.08M$792.50M2/27/2024Q4 2023$0.20$0.64+$0.44$3.19$825.94M$858.23M11/7/2023Q3 2023$0.19$0.19-$3.81$796.60M$804.03M8/8/2023Q2 2023$0.11$0.16+$0.05$0.23$765.69M$793.29M Get the Latest News and Ratings for AHCO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter. 5/9/2023Q1 2023$0.08$0.01 -$0.07$0.08$760.05M$744.63M2/27/2023Q4 2022$0.31$0.01 -$0.30$0.04$787.96M$780.28M AdaptHealth Earnings - Frequently Asked Questions When did AdaptHealth announce their last quarterly earnings? AdaptHealth (NASDAQ:AHCO) last announced its quarterly earning data on Tuesday, November 5, 2024. Learn more on AHCO's earnings history. What guidance has AdaptHealth issued on next quarter's earnings? AdaptHealth updated its FY 2024 earnings guidance on Tuesday, November, 5th. The company issued revenue guidance of $3.2 billion-$3.3 billion, compared to the consensus revenue estimate of $3.3 billion. Did AdaptHealth beat their earnings estimates last quarter? In the previous quarter, AdaptHealth (NASDAQ:AHCO) missed the analysts' consensus estimate of $0.17 by $0.02 with a reported earnings per share (EPS) of $0.15. Learn more on analysts' earnings estimate vs. AHCO's actual earnings. How can I listen to AdaptHealth's earnings conference call? The conference call for AdaptHealth's latest earnings report can be listened to online. Listen to Conference Call How can I read AdaptHealth's conference call transcript? The conference call transcript for AdaptHealth's latest earnings report can be read online. Read Transcript How much revenue does AdaptHealth generate each year? AdaptHealth (NASDAQ:AHCO) has a recorded annual revenue of $3.26 billion. How much profit does AdaptHealth generate each year? AdaptHealth (NASDAQ:AHCO) has a recorded net income of -$678.90 million. AHCO has generated -$1.65 earnings per share over the last four quarters. What is AdaptHealth's price-to-earnings ratio? AdaptHealth (NASDAQ:AHCO) has a forward price-to-earnings ratio of 11.42. The price/earnings-to-growth ratio is 1.36. What is AdaptHealth's EPS forecast for next year? AdaptHealth's earnings are expected to grow from $0.88 per share to $0.95 per share in the next year, which is a 7.95% increase. More Earnings Resources from MarketBeat Related Companies Option Care Health Earnings Results Guardant Health Earnings Results Sotera Health Earnings Results Veracyte Earnings Results BrightSpring Health Services Earnings Results LifeStance Health Group Earnings Results Surgery Partners Earnings Results Concentra Group Holdings Parent Earnings Results Privia Health Group Earnings Results Addus HomeCare Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings Report Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. This page (NASDAQ:AHCO) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdaptHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share AdaptHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
